AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

Ads

You May Also Like

Horizon Pharma plc to Host Fourth-Quarter 2016 Conference Call and Webcast on February 27, 2017

DUBLIN, Ireland, Jan. 27, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical ...

FIT Biotech Oy: FIT Biotech has received a notice from the Finland Arbitration Institute concerning the request by Bracknor Invest to initiate arbitration proceeding under the FAI rules.

FIT Biotech Oy                                                                                                           Company release 3.1.2019 at 15:30 EET FIT Biotech has received a ...